Jerrold F. Rosenbaum, MD

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al

Article

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

March 1, 2004

Jerrold F. Rosenbaum

Article

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

March 1, 2004

Jerrold F. Rosenbaum

Original Research

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

February 1, 2004

George I. Papakostas, Timothy J. Petersen, Andrew A. Nierenberg, et al

Original Research

Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants.

August 15, 2002

Stuart A. Montgomery, Per Bech, Pierre Blier, et al

Article

Introduction: Early Onset of Antidepressant Action

March 1, 2001

Jerrold F. Rosenbaum

Article

An Ideal Trial to Test Differential Onset of Antidepressant Effect

March 1, 2001

Andrew C. Leon, Pierre Blier, Larry Culpepper, et al

Article

Debate and Discussion: Do Some Antidepressants Have a Faster Onset of Action Than Others?

March 1, 2001

Robert M. A. Hirschfeld, Andrew A. Nierenberg, Jack M. Gorman, et al

Original Research

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

November 30, 2000

Steffany J. Fredman, Maurizio Fava, Allison S. Kienke, et al

Original Research

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

July 31, 2000

Patrick J. McGrath, Jonathan W. Stewart, Eva Petkova, et al

Original Research

Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages

September 30, 1999

Georges Moroz, Jerrold F. Rosenbaum

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants.

Introduction: Early Onset of Antidepressant Action

An Ideal Trial to Test Differential Onset of Antidepressant Effect

Debate and Discussion: Do Some Antidepressants Have a Faster Onset of Action Than Others?

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages

ELSEWHERE:

FOLLOW US:

Jerrold F. Rosenbaum, MD

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

The Development of Clonazepam as a Psychotropic: The Massachusetts General Hospital Experience

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

Selecting Methodologies for the Evaluation of Differences in Time to Response Between Antidepressants.

Introduction: Early Onset of Antidepressant Action

An Ideal Trial to Test Differential Onset of Antidepressant Effect

Debate and Discussion: Do Some Antidepressants Have a Faster Onset of Action Than Others?

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic Disorder: A Placebo-Controlled, Multicenter Study Using Optimized Dosages

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles